VANCOUVER, British Columbia -
Oct. 21, 2025 -
PRLog -- As Canada's healthcare landscape evolves, DERMAPPRAISE Digital Check Corp. is advancing the development of its AI-driven mobile dermatology platform to address the growing need for preventive and remote skin-health management. The Canadian telehealth market was valued at USD 13.51 billion in 2024 and is projected to reach USD 42.15 billion by 2030 (Grand View Research). Within this, teledermatology is expected to expand from USD 657 million in 2024 to USD 1.94 billion by 2030, reflecting a 19.3% CAGR (2025–2030)
(Grand View Research). National adoption trends further support this growth: 73.8% of British Columbians reported using a virtual consultation in the past year (Statistics Canada), and the Canadian Institute for Health Information estimates that roughly 9% of emergency-department visits involve conditions potentially manageable through virtual care (CIHI, 2024).
The company's ongoing research focuses on integrating AI-powered skin self-checks, condition tracking, and secure remote consultation features - designed for Canada's diverse geography and healthcare delivery needs. By promoting early detection and continuous engagement, the solution supports national priorities for equitable, preventive, and digitally enabled care. Its emphasis on affordability and scalability aligns with efforts to reduce wait times and travel barriers, particularly in rural and northern communities.
With Canada's virtual-care infrastructure strengthening and investment in digital health accelerating, DERMAPPRAISE Digital Check Corp. remains committed to developing technologies that enhance accessibility, foster patient awareness, and advance sustainable dermatology practices across the country.
About DERMAPPRAISE Digital Check Corp.: DERMAPPRAISE is an artificial intelligence-
powered mobile application designed to revolutionize skin health management by offering personalized, accessible, and convenient dermatological care to users worldwide. Learn more at
https://dermappraise.com/.